Human Organ Regeneration

 

Category: Cell Therapy and Regenerative Medicine

Exhibitor: ACRO BIOMEDICAL CO., LTD.

Booth No: N/A

 

Characteristic

 

The ultimate goal for ACRO’s research on tissue engineering and regenerative medicine is to reconstruct the whole organ in vivo in preparation for successive autologous organ transplantation.

We have succeeded in decellularizing the whole porcine organ such as the heart, liver, kidney, and pancreas by our proprietary supercritical CO2 extraction technology. The decellularized organ scaffold will then be heterotopically transplanted into the abdominal cavity of a live animal with artery and vein reconnected to the organ scaffold. The idea is that the blood circulation will bring in the stem cells needed for organ reconstruction. From our previous experience in cornea, skin, and cartilage reconstruction, the regeneration process took about a month for full reconstruction of the tissues. If the porcine organ scaffold can be reconstructed in the human body within one to three months, we will have the source of organs for autologous organ transplantation in the near future. The patients will no longer have to wait in line for organ donation and suffer from the severe adverse effects of organ rejection.

 

Other Products

 

• 

  ABCcolla® Scar Care Series

• 

  ABCcolla® Collagen Membrane

• 

  ABCcolla® Collagen Bone Matrix

• 

  ABCcolla® EZ Collagen Bone Graft(Moldable)

• 

  ABCcolla® Collagen Matrix

• 

  ACRODERM Collagen Skincare Series

• 

  ABCcolla® Collagen Ophthalmic Matrix

• 

  iMist Collagen Mist Spray

• 

  ABCcolla® Collagen Dental Bone Graft

 

 

 

Back